Developing vaccines for Chronic Wasting Disease in deer
Chronic Wasting Disease Vaccines
This study is testing new vaccines to help protect deer from Chronic Wasting Disease (CWD), which is important for hunters and wildlife lovers, and aims to see how well these vaccines work and if they are safe for the deer.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Colorado State University NIH-funded |
| Lab location | 1 site (Fort Collins, United States) |
| Project ID | NIH-10873970 on NIH RePORTER |
What this research studies
This research focuses on creating effective vaccines to protect deer from Chronic Wasting Disease (CWD), a serious prion disease affecting cervids. The team is utilizing innovative vaccine strategies that have shown promise in animal models, aiming to assess their efficacy and safety in a controlled environment. By monitoring the immune response and potential prion shedding in deer, the research seeks to establish a viable preventative measure against this rapidly spreading disease. The study is significant due to the public health implications of CWD, especially for hunters and wildlife enthusiasts.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include hunters and wildlife enthusiasts who may be exposed to CWD through deer consumption.
Not a fit: Patients who do not hunt or consume deer products may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that protect deer from CWD, thereby reducing the risk of transmission to humans and other animals.
How similar studies have performed: While there has been limited success in developing vaccines for prion diseases, this approach is innovative and aims to address a significant gap in current preventive measures.
Where this research is happening
Fort Collins, United States
- Colorado State University — Fort Collins, United States (Active)
Researchers
- Principal investigator: Mathiason, Candace K. — Colorado State University
- Study coordinator: Mathiason, Candace K.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.